Skip to content

Continuing Care for Justice-involved Individuals

Continuing Care App for Justice-Involved Individuals With Substance Use Disorders

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07593274
Acronym
CCapp
Enrollment
31
Registered
2026-05-18
Start date
2025-05-08
Completion date
2025-12-31
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use Disorder (SUD)

Keywords

substance use disorder, justice involved, community treatment

Brief summary

The goal of this open label feasibility trial is to determine the feasibility of using a mobile continuing care app to augment community treatment for individuals under justice supervision receiving community substance use disorder treatment.

Detailed description

A four-week feasibility trial of the CC app with a sample individuals on probation and parole with SUDs who are receiving outpatient substance use disorder treatment will be recruited and use the app for 12 weeks during community treatment. Study participants will complete brief questionnaires at study initiation (focusing on background characteristics, treatment history, app expectations) and after the 4-week feasibility trial (focusing on their experiences with the app, usability, satisfaction, and suggestions for improvement).

Interventions

DEVICEcontinuing care app

continuing care app is an app on a smartphone

Sponsors

Friends Research Institute, Inc.
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

continuing care app

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1\) age 18 or older, 2) currently on probation or parole, 3) currently a client receiving outpatient substance use treatment at one of the three participating clinics, 4) willing to receive supplemental treatment services through a mobile app, and 5) willing to provide informed consent and complete research assessments

Exclusion criteria

1\) Active medical history that may preclude participation (e.g., requires higher level of care; active psychosis; compromised comprehension)

Design outcomes

Primary

MeasureTime frameDescription
app usability12 weeks post baselineQuestions about usability will be asked using the System Usability Scale (SUS), one of the most widely used standardized measures to assess technology usability. Using this scale, participants are asked to provide a score for 10-items, using 5-point Likert scales, regarding: a) ease of use, and b) learnability.
Feasibility and Satisfaction Survey12-weeks post-baselineFeasibility and Satisfaction Survey (FSS) that was developed and used in our prior research and will be used to assesses feasibility and satisfaction. Questions will consist of 5-point Likert scales and open-ended questions focused on: 1) program utilization \[frequency of reviewing app content\], 2) overall look, feel, and experience, 3) ease of use, and 4) app content/tools (i.e., relevance, usefulness, and engagement).

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMichael S Gordon, DPA

Friends Research Institute, Inc.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 19, 2026